Yoshitake T, Kehr J, Todoroki K, Nohta H, Yamaguchi M
Department of Physiology and Pharmacology, Nanna Svartz väg 2, Karolinska Institutet, Stockholm, Sweden.
Biomed Chromatogr. 2006 Mar;20(3):267-81. doi: 10.1002/bmc.560.
The present paper provides an overview on currently developed derivatization chemistries and techniques for determination of monoamine neurotransmitters serotonin (5-HT), norepinephrine (NE) and dopamine (DA) in microdialysis samples by microbore liquid chromatography with fluorescence detection. In mild alkaline conditions, 5-hydroxyindoles and catecholamines react with benzylamine (BA), forming highly fluorescent 2-phenyl-4,5-pyrrolobenzoxazoles and 2-phenyl(4,5-dihydropyrrolo) [2,3-f]benzoxazoles, respectively. However, for derivatization of DA a higher fluorescence intensity was achieved for reaction with 1,2-diphenylethylenediamine (DPE) rather than with BA, therefore for simultaneous determination of 5-HT, NE and DA in brain microdialysates, a two-step derivatization with BA followed by DPE was developed. The detection limits for 5-HT, NE and DA were 0.2, 0.08 and 0.13 fmol, respectively, in an injection volume of 20 microL, which corresponds to concentrations of 30, 12 and 19.5 pm, respectively in standard solution prior to derivatization. The experimental data presented demonstrate the ability of the technique to simultaneously monitor neuronally releasable pools of monoamine neurotransmitters in the rat and mouse brains at basal conditions and following pharmacological treatments or physiological stimuli. These techniques play an important role in drug discovery and clinical investigation of psychiatric and neurological diseases such as depression, schizophrenia and Parkinson's disease.
本文概述了目前开发的衍生化化学方法和技术,用于通过微径液相色谱-荧光检测法测定微透析样品中的单胺类神经递质5-羟色胺(5-HT)、去甲肾上腺素(NE)和多巴胺(DA)。在温和碱性条件下,5-羟吲哚和儿茶酚胺与苄胺(BA)反应,分别形成高荧光的2-苯基-4,5-吡咯并苯并恶唑和2-苯基(4,5-二氢吡咯并)[2,3-f]苯并恶唑。然而,对于DA的衍生化,与1,2-二苯基乙二胺(DPE)反应比与BA反应获得更高的荧光强度,因此,为了同时测定脑微透析液中的5-HT、NE和DA,开发了先用BA然后用DPE的两步衍生化方法。在进样体积为20微升时,5-HT、NE和DA的检测限分别为0.2、0.08和0.13飞摩尔,这分别对应于衍生化前标准溶液中30、12和19.5皮摩尔的浓度。所呈现的实验数据证明了该技术在基础条件下以及在药理治疗或生理刺激后同时监测大鼠和小鼠脑中可被神经元释放的单胺类神经递质池的能力。这些技术在药物发现以及抑郁症、精神分裂症和帕金森病等精神和神经疾病的临床研究中发挥着重要作用。